Adult-onset presentation of a hyperornithinemia-hyperammonemia-homocitrullinuria patient without prior history of neurological complications

JIMD Reports

Volumn 3, Issue , 2012, Pages 97-102

  Tezcan, Kamer ^a   Louie, Kristal T ^a   Qu, Yong ^a   Velasquez, Jorge ^b   Zaldivar, Frank ^b   Rioseco Camacho, Natalia ^b   Camacho, José Angel ^b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amino acid profile; Cationic amino acid; Orotic acid; Plasma ammonia; Vegetarian diet

Indexed keywords

EID: 84893706784     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2011_71     Document Type: Chapter

References (14)

1. Al-Hassnan ZN, Rashed MS, Al-Dirbashi OY et al (2008) Hyper-ornithinemia-Hyperammonemia-Homocitrullinuria syndrome with stroke-like imaging presentation: clinical, biochemical and molecular analysis. J Neurol Sci 264:187–194
2. Brusilow SW, Horwich AL (2001) Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 1909–1964
3. Camacho JA, Rioseco-Camacho N (2009) The human and mouse SLC25A29 mitochondrial transporters rescue the deficient ornithine metabolism in fibroblasts of patients with the Hyper-ornithinemia-Hyperammonemia-Homocitrullinuria (HHH) syndrome. Pediatr Res 66:35–41
4. Camacho JA, Rioseco-Camacho N, Andrade D et al (2003) Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome, a urea cycle disorder. Mol Genet Metab 79:257–271
5. Camacho JA, Mardach R, Rioseco-Camacho N et al (2006) Clinical and functional characterization of a human ORNT1 mutation (T32R) in the Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) syndrome. Pediatr Res 60:423–429
6. Debray FG, Lambert M, Lemieux B et al (2008) Phenotypic variability among patients with Hyperornithinaemia-Hyperam-monaemia-Homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15. J Med Genet 45:759–764
7. Humm A, Fritsche E, Steinbacher S et al (1997) Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. EMBO J 16:3373–3385
8. Korman SH, Kanazawa N, Abu-Libdeh B et al (2004) Hyper-ornithinemia-Hyperammonemia-Homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family. J Neurol Sci 218:53–58
9. Palmieri F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777:564–578
10. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35
11. Tessa A, Fiermonte G, Dionisi-Vici C et al (2009) Identification of novel mutations in the SLC25A15 gene in Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study. Hum Mutat 30:741–748
12. Torisu H, Kira R, Kanazawa N et al (2006) A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome. Brain Dev 28:332–335
13. Valle D, Simell O (2001) The hyperornithinemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 1857–1896
14. Viegas CM, Busanello EN, Tonin AM et al (2011) Dual mechanism of brain damage induced in vivo by the major metabolites accumulating in Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome. Brain Res 1369:235–244